On Tuesday, Atyr Pharma Inc (NASDAQ: ATYR) was -11.34% drop from the session before settling in for the closing price of $4.32. A 52-week range for ATYR has been $1.42 – $4.66.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 545.22%. When this article was written, the company’s average yearly earnings per share was at 3.09%. With a float of $81.24 million, this company’s outstanding shares have now reached $83.94 million.
The extent of productivity of a business whose workforce counts for 59 workers is very important to gauge. In terms of profitability, gross margin is -563.83%, operating margin of -28958.72%, and the pretax margin is -27155.32%.
Atyr Pharma Inc (ATYR) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Atyr Pharma Inc stocks. The insider ownership of Atyr Pharma Inc is 3.22%, while institutional ownership is 65.86%. The most recent insider transaction that took place on Feb 04 ’25, was worth 4,740. In this transaction Chief Financial Officer of this company sold 1,254 shares at a rate of $3.78, taking the stock ownership to the 31,763 shares. Before that another transaction happened on Feb 04 ’25, when Company’s General Counsel sold 899 for $3.78, making the entire transaction worth $3,398. This insider now owns 26,555 shares in total.
Atyr Pharma Inc (ATYR) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.29% during the next five years compared to 43.36% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
You can see what Atyr Pharma Inc (ATYR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1397.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
The latest stats from [Atyr Pharma Inc, ATYR] show that its last 5-days average volume of 2.18 million was superior to 1.01 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 65.49%. Additionally, its Average True Range was 0.31.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 72.24%, which indicates a significant increase from 35.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 96.21% in the past 14 days, which was higher than the 79.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.61, while its 200-day Moving Average is $2.53. Now, the first resistance to watch is $4.21. This is followed by the second major resistance level at $4.59. The third major resistance level sits at $4.78. If the price goes on to break the first support level at $3.64, it is likely to go to the next support level at $3.45. Assuming the price breaks the second support level, the third support level stands at $3.07.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
There are 83,942K outstanding shares of the company, which has a market capitalization of 321.50 million. As of now, sales total 350 K while income totals -50,390 K. Its latest quarter income was 0 K while its last quarter net income were -16,310 K.
